Europe Hereditary Testing Market Size & Outlook, 2023-2030
Europe hereditary testing market, 2018-2030 (US$M)
Related Markets
Europe hereditary testing market highlights
- The Europe hereditary testing market generated a revenue of USD 2,511.3 million in 2023.
- The market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, hereditary non-cancer testing was the largest revenue generating disease type in 2023.
- Hereditary Cancer Testing is the most lucrative disease type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 2,511.3 million |
| Market revenue in 2030 | USD 4,227.9 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Hereditary non-cancer testing |
| Fastest growing segment | Hereditary Cancer Testing |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hereditary Cancer Testing, Hereditary Non-cancer Testing |
| Key market players worldwide | Myriad Genetics Inc, Invitae Corp, Illumina Inc, Natera Inc, Labcorp Holdings Inc, Roche Holding AG ADR, Quest Diagnostics Inc, CooperSurgical, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Twist Bioscience Corp, Sophia Genetics SA, Fulgent Genetics Inc, MedGenome, Centogene NV Ordinary Shares, The Cooper Companies Inc |
Other key industry trends
- In terms of revenue, Europe region accounted for 34.6% of the global hereditary testing market in 2023.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,021.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hereditary Testing Market Scope
Hereditary Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe hereditary testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hereditary testing market will help companies and investors design strategic landscapes.
Hereditary non-cancer testing was the largest segment with a revenue share of 84.31% in 2023. Horizon Databook has segmented the Europe hereditary testing market based on hereditary cancer testing, hereditary non-cancer testing covering the revenue growth of each sub-segment from 2018 to 2030.
Europe dominated the global hereditary testing market in terms of revenue generation in 2018. The presence of several supportive programs or projects—initiated by both public and private entities—to improve access to genetic testing in European countries results in the region’s leading share in the market. The EuroGentest2 project, funded by European Commission, streamlines the process of genetic testing, and enhances the quality of genetic services.
Council of Europe focuses on ethical & legal issues caused by application of genetic testing and protects fundamental human rights to access them. The presence of public agency projects that promote safe and accurate genetic testing across Europe is expected to boost demand for hereditary testing. The presence of several key companies that provide hereditary testing solutions additionally contributes to the leading share of Europe.
Growth initiatives are undertaken by key vendors to improve adoption of hereditary testing in Europe, supplementing the market’s revenue. For instance, in November 2019, Centogene N.V. and PTC Therapeutics, Inc. entered into an agreement for a diagnostic program on a rare inherited disorder, Aromatic L-amino Acid Decarboxylase (AADC) deficiency. As per the agreement, Centogene would support PTC Therapeutics for this diagnostic program to assist patients suffering from AADC deficiency.
Reasons to subscribe to Europe hereditary testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe hereditary testing market databook
-
Our clientele includes a mix of hereditary testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe hereditary testing market, including forecasts for subscribers. This continent databook contains high-level insights into Europe hereditary testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe hereditary testing market size, by country, 2018-2030 (US$M)
Europe Hereditary Testing Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
